Clinical Trials Logo

Endometrial Adenoacanthoma clinical trials

View clinical trials related to Endometrial Adenoacanthoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00025467 Completed - Clinical trials for Endometrial Adenocarcinoma

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Start date: September 2001
Phase: Phase 2
Study type: Interventional

Phase II trial to study the effectiveness of thalidomide in treating patients who have recurrent or persistent endometrial cancer. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor